Physician profile
Peter Y Shin
NPI 1194917963
$870.47
in general payments reported to CMS, 2019-2025
18 companies · $45.52 in 2025
The $45.52 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $77.91 · 2020: $102 · 2021: $107 · 2022: $66.71 · 2023: $32.78 · 2024: $438 · 2025: $45.52.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $516.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $516.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $366.83 | 2024 | Impella |
| Abbvie INC. | $120.92 | 2021-2025 | Dalvance |
| Allergan, INC. | $89.57 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $39.08 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $36.15 | 2019-2022 | |
| Viatris Specialty LLC | $30.29 | 2025 | Yupelri |
| Janssen Pharmaceuticals, INC | $28.68 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $19.86 | 2024 | Dificid, Zerbaxa |
| Smith+Nephew, INC. | $16.94 | 2024 | Collagenase Santyl |
| Amgen INC. | $16.73 | 2023 | Repatha |
| Pfizer INC. | $15.00 | 2022 | |
| Medtronic Vascular, INC. | $14.62 | 2019 | |
| Novartis Pharmaceuticals Corporation | $14.35 | 2020 | |
| Portola Pharmaceuticals, LLC | $14.05 | 2019 | |
| Gilead Sciences, INC. | $12.80 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.37 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $11.25 | 2019 | |
| Melinta Therapeutics, LLC | $10.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Shin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.